Namenda Buyers Say Product Hopping Class Action Has Legs

By Kelly Knaub · February 2, 2016, 12:05 AM EST

Drug wholesalers accusing Actavis and Merz of trying to stall the release of a generic version of the Alzheimer's treatment Namenda urged a New York federal judge Friday not to toss...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum of Law in Opposition to Motion

Case Information

Case Title

In Re Namenda Direct Purchaser Antitrust Litigation

Case Number

Court

New York Southern

Nature of Suit

Anti-Trust

Date Filed

September 22, 2015

Recent Articles By Kelly

March 28, 2018
Pharmacy Owner Gets 5 Years For $10.5M Tricare Fraud
October 19, 2017
Gov't To Face ACLU At DC Circ. On Immigrant Teen's Abortion
July 14, 2017
Womble Carlyle Boosts IP Group With Ex-Alston & Bird Atty
June 29, 2017
Winstead Boosts Texas Offices With 5 New Attys
May 08, 2017
Immigrant Deaths Due To Poor Care In Detention: Report
March 13, 2017
Fed. Circ. Affirms Medical Billing Patent Invalid Under Alice
January 30, 2017
Small Pharmacies Seek Redo In Medco Antitrust Row
January 06, 2017
Docs Must Meet US Acclaim Standards For Exam Exemption
December 13, 2016
EEOC Details Rights Of Workers With Mental Conditions
December 05, 2016
EB-5 Applicants Seek Judgment In Hospital Row